NDC 42023-221-01 - ERTAPENEM
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42023-221
- Requested NDC
- 42023-221-01
- Package NDCs from labels
- 42023-221-89, 42023-221-85, 42023-221-01, 42023-221-10
- Manufacturer
- ENDO USA, Inc. | Merck Sharp & Dohme LLC
- Effective date
- 2026-03-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ERTAPENEM - ENDO USA, Inc. | Merck Sharp & Dohme LLC | ENDO USA, Inc. | Merck Sharp & Dohme LLC | 2026-03-02 | HUMAN PRESCRIPTION DRUG LABEL |
| ERTAPENEM - ENDO USA, Inc. | Merck Sharp & Dohme LLC | ENDO USA, Inc. | Merck Sharp & Dohme LLC | 2026-03-02 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42023-221-01 | ERTAPENEM | 1 in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 1 | 13 | |
| 42023-221-10 | ERTAPENEM | 10 in 1 PACKAGE | INJECTION, POWDER, LYOPHILIZED, | 10 | 13 | |
| 42023-221-85 | ERTAPENEM | 10 in 1 PACKAGE | INJECTION, POWDER, LYOPHILIZED, | 10 | 13 | |
| 42023-221-89 | ERTAPENEM | 1 in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 1 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 42023-221 | ERTAPENEM (ERTAPENEM SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ENDO USA, INC.] | 10 | Current NDC, Legacy NDC, 2 package rows | 20240716_657855f2-7c92-4aa8-9c3d-51d08e56a09a.zip |
| 42023-221 | ERTAPENEM (ERTAPENEM SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ENDO USA, INC.] | 9 | Current NDC, Legacy NDC, 2 package rows | 20240716_41304b1d-7db4-468a-ab1d-04e56fb50de4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42023-221-01 | EA - Each | 42023-221 | ab48327d-4a9d-49ae-93cb-36b2e50be6f2 | 1 | 2018-08-13 |
| 42023-221-10 | EA - Each | 42023-221 | 5bce14c2-8926-4eb4-a8cc-2bba14d9ebd9 | 1 | 2018-08-13 |
| 42023-221-85 | EA - Each | 42023-221 | cca54412-b1b8-4749-9c80-0c30149b3ec6 | 1 | 2018-12-13 |
| 42023-221-89 | EA - Each | 42023-221 | 014f44b1-2664-42fc-bdd2-c33f5769861b | 1 | 2018-12-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Publix Fast Relief Effervescent | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Publix Super Markets Inc. | 73051f16-2569-7394-e053-2991aa0a5359 | 2024-11-13 | Warnings | 8MDF5V39QO |
| Quality Choice Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Chain Drug Marketing Association | 70d265de-ff94-e0e4-e053-2a91aa0a962a | 2024-11-13 | Warnings | 8MDF5V39QO |
| Quality Choice Extra Strength Effervescent Antacid and Pain Relief | ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE | Chain Drug Marketing Association | 9f7d0c96-a561-a8a0-e053-2995a90a250b | 2024-11-13 | Warnings | 8MDF5V39QO |
| WinCo Foods Effervescent Antacid and Pain Relief | ASPIRIN, SODIUM BICARBONATE, CITRIC ACID TABLET | WinCo Foods, LLC | 0c8a755a-089f-477f-97e9-0dd6fdfbe99d | 2024-11-13 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Cardinal Health 107, LLC | f7c88834-aa7c-4aaa-ab9b-0cbcd1f4da3f | 2024-11-07 | Warnings | 8MDF5V39QO |
| ertapenem sodium | ERTAPENEM SODIUM | Hikma Pharmaceuticals USA, Inc. | a400707f-763f-43f6-989e-0d2569d822d8 | 2024-11-06 | Warnings, Adverse reactions | 1734683 2T90KE67L0 |
| Ertapenem | ERTAPENEM | Hospira, Inc. | 178a0356-4f6c-47fb-9913-f325a3c72f7b | 2024-11-06 | Warnings, Adverse reactions | 1734683 2T90KE67L0 |
| Ertapenem | ERTAPENEM SODIUM | Hikma Pharmaceuticals USA Inc. | b88c0709-33fe-47db-8ae8-8bad6692d5d5 | 2024-11-05 | Warnings, Adverse reactions | 1734683 2T90KE67L0 |
| Sodium Bicarbonate | SODIUM BICARBONATE | Rising Pharma Holdings, Inc. | f5a90c33-f29d-4d4b-b5e6-0b3c2514ce3e | 2024-11-01 | Boxed warning, Warnings | 8MDF5V39QO |
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | ScieGen Pharmaceuticals, Inc. | a107804e-b308-4e79-9447-07d93016f70f | 2024-10-24 | Warnings, Adverse reactions | 8MDF5V39QO |
| OHTAS ISAN ANTACID | CALCIUM CARBONATE, SODIUM BICARBONATE | OHTA'S ISAN CO.,LTD. | 53380470-5748-6fa7-548e-7484ef204c0f | 2024-10-21 | Warnings | 8MDF5V39QO |
| OHTAS ISAN ANTACID | CALCIUM CARBONATE, SODIUM BICARBONATE | OHTA'S ISAN CO.,LTD. | 8723fe90-8402-4511-b6c6-b71cf98513e3 | 2024-10-21 | Warnings | 8MDF5V39QO |
| Elliotts B | SODIUM CATION, SODIUM BICARBONATE, ANHYDROUS DEXTROSE, MAGNESIUM SULFATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM PHOSPHATE | Lukare Medical, LLC | 08036dbd-55b3-47b9-9890-000f253544f3 | 2024-10-16 | Warnings, Adverse reactions | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE INJECTION, | Long Grove Pharmaceuticals, LLC | a26d709b-b294-4b02-9a88-7e840f099a33 | 2024-09-25 | Warnings, Adverse reactions | 8MDF5V39QO |
| Insect sting relief latex 01 | SODIUM BICARBONATE | Cosmuses Cosmetics (Ningbo) Co., Ltd. | 1b9e2d4c-bc0c-6ed0-e063-6294a90a9103 | 2024-08-19 | Warnings | 8MDF5V39QO |
| Quality Choice Effervescent Antacid and Pain Relief - Extra Strength | ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE | Chain Drug Marketing Association | 1f926637-a61c-8eb7-e063-6394a90a6502 | 2024-08-13 | Warnings | 8MDF5V39QO |
| Omeprazole/Sodiium Bicarbonate | OMEPRAZOLE/SODIIUM BICARBONATE | Direct_rx | 1f7f63c1-17c2-9a05-e063-6394a90abc6f | 2024-08-12 | Warnings, Adverse reactions | 8MDF5V39QO |
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | Dr. Reddy's Laboratories Inc., | ddee28fb-c871-a6d4-984f-515522b28412 | 2024-07-15 | Warnings | 8MDF5V39QO |
| Ertapenem | ERTAPENEM | Eugia US LLC | f725a68c-31a2-482a-9744-19adc47506b5 | 2024-07-09 | Warnings, Adverse reactions | 1734683 2T90KE67L0 |
| Ertapenem | ERTAPENEM | Eugia US LLC | 31bcf16f-e0c1-47d1-9852-de898a856f6e | 2024-07-09 | Warnings, Adverse reactions | 1734683 2T90KE67L0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.